July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Association Between Symptoms and Signs of Dry Eye after Allogeneic Hematopoietic Stem Cell Transplantation
Author Affiliations & Notes
  • Da Yeong Kim
    Department of Ophthalmology, Yeouido St. Mary’s Hospital, Seoul, Korea (the Republic of)
  • Dae Yu kim
    Department of Electrical Engineering, Inha University, Incheon, Korea (the Republic of)
  • Hyun Seung Kim
    Department of Ophthalmology, Yeouido St. Mary’s Hospital, Seoul, Korea (the Republic of)
  • Kyung-Sun Na
    Department of Ophthalmology, Yeouido St. Mary’s Hospital, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Da Yeong Kim, None; Dae Yu kim, None; Hyun Seung Kim, None; Kyung-Sun Na, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 954. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Da Yeong Kim, Dae Yu kim, Hyun Seung Kim, Kyung-Sun Na; Association Between Symptoms and Signs of Dry Eye after Allogeneic Hematopoietic Stem Cell Transplantation. Invest. Ophthalmol. Vis. Sci. 2018;59(9):954.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry eye disease (DED) is common in patients with chronic graft-versus-host disease (GHVD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and is currently listed as a distinctive sign for the diagnosis of chronic ocular GVHD. The aim of the present study was to analyze the association between the signs and symptoms of DED within a short period after allo-HSCT.

Methods : We retrospectively analyzed the medical charts of 96 patients who were available for evaluation before and 6 months after allo-HSCT. Subjective symptoms were assessed using the Ocular Surface Disease Index (OSDI) questionnaire. Parameters pertaining to clinical signs associated with the ocular surface and tear dynamics were also evaluated, including tear osmolarity, Schirmer values without anesthesia, the tear break-up time (TBUT), and corneal fluorescein staining (CFS) scores.

Results : There was a significant positive correlation between changes in OSDI and CFS scores after allo-HSCT. The number of patients who reported alleviated symptoms not corresponding to objective findings was greater among men than among women.

Conclusions : Our findings suggest that evaluation of the subjective symptoms of DED alone may be insufficient for the diagnosis of ocular GVHD. Physicians should schedule regular ophthalmological examinations after allo-HSCT rather than relying on the Schirmer test or subjective symptoms.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×